Original Article

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
  • Yeşim Eralp
  • Leyla Kılıç
  • Gül Alço
  • Gül Başaran
  • Mutlu Doğan
  • Dilek Dinçol
  • Senem Demirci
  • Fikri İçli
  • Handan Onur
  • Pınar Saip
  • Ayfer Haydaroğlu
Eur J Breast Health 2014; 10: 209-215 DOI: 10.5152/tjbh.2014.1904
Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients
  • Rabia Doğukan
  • Ramazan Uçak
  • Fatih Mert Doğukan
  • Canan Tanık
  • Bülent Çitgez
  • Fevziye Kabukcuoğlu
Eur J Breast Health 2019; 15: 235-241 DOI: 10.5152/ejbh.2019.4912
Does a 40% Cut-off Point for Ki-67 Expression Have a Role in Identifying the Development of Distant Metastasis Within 2 Years in Locally Advanced Triple Negative Breast Cancer Patients?
  • Kelvin Setiawan
  • Ida Bagus Suryawisesa
  • I Ketut Widiana
  • I Wayan Sudarsa
Eur J Breast Health 2023; 19: 274-278 DOI: 10.4274/ejbh.galenos.2023.2023-4-5 PMID:37794999
Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
  • Özgecan Dülgar
  • Şennur İlvan
  • Zeynep Hande Turna
Eur J Breast Health 2020; 16: 276-281 DOI: 10.5152/ejbh.2020.5305